Potential target pathway may pave way for new therapeutic approaches for fragile X syndrome, autism

16 julio 2015

The protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages, a new study suggests. Researchers identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/GU2tIOm3lC0″ height=»1″ width=»1″ alt=»»/